JP2012521966A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521966A5
JP2012521966A5 JP2011553339A JP2011553339A JP2012521966A5 JP 2012521966 A5 JP2012521966 A5 JP 2012521966A5 JP 2011553339 A JP2011553339 A JP 2011553339A JP 2011553339 A JP2011553339 A JP 2011553339A JP 2012521966 A5 JP2012521966 A5 JP 2012521966A5
Authority
JP
Japan
Prior art keywords
pain
urinary incontinence
epilepsy
mania
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011553339A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012521966A (ja
JP5727945B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/001449 external-priority patent/WO2010102779A1/de
Publication of JP2012521966A publication Critical patent/JP2012521966A/ja
Publication of JP2012521966A5 publication Critical patent/JP2012521966A5/ja
Application granted granted Critical
Publication of JP5727945B2 publication Critical patent/JP5727945B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011553339A 2009-03-10 2010-03-09 Kcnq2/3モジュレータとしての置換された3−アミノ−2−メルカプトキノリン Expired - Fee Related JP5727945B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09003431 2009-03-10
EP09003431.5 2009-03-10
PCT/EP2010/001449 WO2010102779A1 (de) 2009-03-10 2010-03-09 Substituierte 3-amino-2-mercaptochinoline als kcnq2/3 modulatoren

Publications (3)

Publication Number Publication Date
JP2012521966A JP2012521966A (ja) 2012-09-20
JP2012521966A5 true JP2012521966A5 (https=) 2014-10-16
JP5727945B2 JP5727945B2 (ja) 2015-06-03

Family

ID=40591941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011553339A Expired - Fee Related JP5727945B2 (ja) 2009-03-10 2010-03-09 Kcnq2/3モジュレータとしての置換された3−アミノ−2−メルカプトキノリン

Country Status (22)

Country Link
US (1) US8207342B2 (https=)
EP (1) EP2406228B1 (https=)
JP (1) JP5727945B2 (https=)
KR (1) KR20110130461A (https=)
CN (1) CN102341374A (https=)
AR (1) AR075730A1 (https=)
AU (1) AU2010223556B2 (https=)
BR (1) BRPI1009519A2 (https=)
CA (1) CA2754943A1 (https=)
CL (1) CL2011002160A1 (https=)
CO (1) CO6410291A2 (https=)
EC (1) ECSP11011346A (https=)
ES (1) ES2436365T3 (https=)
IL (1) IL214944A0 (https=)
MX (1) MX2011009338A (https=)
NZ (1) NZ595569A (https=)
PE (1) PE20120535A1 (https=)
PL (1) PL2406228T3 (https=)
RU (1) RU2011140701A (https=)
TW (1) TWI504395B (https=)
WO (1) WO2010102779A1 (https=)
ZA (1) ZA201107370B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2754934A1 (en) * 2009-03-10 2010-09-16 Gruenenthal Gmbh Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
TWI461197B (zh) * 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
MX342459B (es) 2010-08-27 2016-09-29 Grünenthal Gmbh * 2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas sustituidas, como moduladores de kcnq2/3.
CA2805932A1 (en) 2010-08-27 2012-03-01 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
RU2595894C2 (ru) 2010-08-27 2016-08-27 Грюненталь Гмбх Замещенные 2-окси-хинолин-3-карбоксамиды в качестве модуляторов kcnq2/3
CA2807886A1 (en) 2010-09-01 2012-03-08 Gruenenthal Gmbh Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
DE102018212006B3 (de) * 2018-07-18 2019-10-31 Universität Greifswald Thioether als Modulatoren von Kv7.2/Kv7.3-Kanälen

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706977A1 (de) 1977-02-18 1978-08-24 Hoechst Ag Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
FR2532939A1 (fr) 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
DE4032147A1 (de) 1990-10-10 1992-04-16 Bayer Ag Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung
US5583147A (en) * 1994-03-23 1996-12-10 The Dupont Merck Pharmaceutical Company Amides for the treatment of atherosclerosis
EP0716077A1 (de) 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
WO1996026925A1 (en) 1995-03-01 1996-09-06 Banyu Pharmaceutical Co., Ltd. Arylthioacetamide derivatives
AU742452B2 (en) * 1997-08-28 2002-01-03 Bristol-Myers Squibb Company 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
DE19738616A1 (de) 1997-09-04 1999-03-11 Clariant Gmbh 4-Hydroxychinolin-3-carbonsäure-Derivate als Lichtschutzmittel
WO2000042026A1 (en) 1999-01-15 2000-07-20 Novo Nordisk A/S Non-peptide glp-1 agonists
EP1200086A4 (en) 1999-08-04 2009-05-27 Icagen Inc THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
ATE380176T1 (de) 1999-08-04 2007-12-15 Icagen Inc Benzanilide als öffner des kaliumkanals
CA2438868A1 (en) 2001-02-20 2002-09-19 Valentin K. Gribkoff Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases
CZ20032233A3 (cs) 2001-02-20 2004-12-15 Bristol-Myers Squibb Company Derivát 2,4-disubstituovaného pyrimidin-5-karboxamidu jako modulátor draslíkového kanálku KCNQ
US6593349B2 (en) 2001-03-19 2003-07-15 Icagen, Inc. Bisarylamines as potassium channel openers
EP1372654A4 (en) 2001-04-06 2007-10-03 Smithkline Beecham Corp QUINOLINE INHIBITORS OF HYAK1 AND HYAK3 KINASES
AU2003272552A1 (en) 2002-09-17 2004-04-08 Pharmacia Corporation Aromatic liver x-receptor modulators
ATE488231T1 (de) 2002-12-23 2010-12-15 Icagen Inc Quinazolinone als kaliumkanalmodulatoren
EP1449841A1 (en) 2003-02-19 2004-08-25 Bayer CropScience SA New fungicidal compounds
MXPA06004005A (es) 2003-10-08 2006-06-28 Vertex Pharma Moduladores de transportadores con casete de union con atp.
JP4054369B2 (ja) 2004-05-04 2008-02-27 ファイザー株式会社 オルト置換アリールまたはヘテロアリールアミド化合物
WO2006051311A1 (en) 2004-11-12 2006-05-18 Galapagos Nv Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
EP1861394A1 (en) 2005-03-03 2007-12-05 H.Lundbeck A/S Substituted pyridine derivatives
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
EP1912946B1 (en) 2005-07-20 2009-05-27 Eli Lilly And Company Pyridine derivatives as dipeptedyl peptidase inhibitors
CN101277939A (zh) 2005-09-09 2008-10-01 布里斯托尔-迈尔斯斯奎布公司 无环ikur抑制剂
WO2007057447A1 (en) * 2005-11-18 2007-05-24 Neurosearch A/S Novel quinazoline derivatives and their medical use
CA2658190C (en) 2006-07-20 2013-01-29 Amgen Inc. Di-amino-substituted heterocyclic compounds and methods of use
AU2007275653B2 (en) 2006-07-20 2010-12-23 Amgen Inc. Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine
US20100022589A1 (en) 2006-07-27 2010-01-28 Mccoull William Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
DE102006049452A1 (de) 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
JP5341084B2 (ja) 2007-08-03 2013-11-13 エフ.ホフマン−ラ ロシュ アーゲー Taar1リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
EP2215065B1 (en) 2007-10-19 2012-07-11 Boehringer Ingelheim International GmbH Ccr10 antagonists
CA2754934A1 (en) 2009-03-10 2010-09-16 Gruenenthal Gmbh Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
TWI461197B (zh) * 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier

Similar Documents

Publication Publication Date Title
JP2012520249A5 (https=)
JP2012521966A5 (https=)
JP2018513107A5 (https=)
JP2009510044A5 (https=)
JP2015535270A5 (https=)
JP2009533356A5 (https=)
MY167423A (en) Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators,compositions,and their use
NZ591326A (en) An extended release pharmaceutical composition of entacapone or salts thereof
EA201891374A1 (ru) Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение
RU2018138183A (ru) Оксистеролы и способы их применения
EP4215185A8 (en) Method for bowel preparation
JP2015512386A5 (https=)
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
WO2008087461B1 (en) Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
JP2013516475A5 (https=)
Khasanov et al. Optimization of the diagnosis of ronchopathy in patients with diseases of ent-organs
WO2017119456A1 (ja) せん妄の予防または治療剤
CL2014001046A1 (es) Proceso de preparacion de compuestos derivados de acilguanidinas y aciltioureas, utiles para el tratamiento de enfermedades de los pulmones y de las vias respiratorias; y compuestos intermediarios utilizados en dicho proceso.
WO2012038850A8 (en) Pyrimidones for treatment of potassium channel related diseases
FR2974512B1 (fr) Composition anti-inflammatoire de l'intestin comprenant du maltitol
HRP20160832T1 (hr) Liječenje osteoporoze
JP2010195697A5 (https=)
Han et al. A retrospective study of 54 cases with chronic otitis media prepared for staging tympanoplasty
Berg et al. Gynecological Consequences of Female Genital Mutilation/Cutting (FGM/C)[Internet]
Deng et al. Distribution of electroencephalograph power density in patients with severe obstructive sleep apnea during different sleep stages